ArticleNoro psikiyatri arsivi2026
A Case of Dose-Dependent Lamotrigine-Induced Priapism in a Patient with Bipolar Disorder.
Article in Noro psikiyatri arsivi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Priapism is defined as a prolonged and persistent erection of the penis without sexual stimulation. Priapism can be caused either by organic factors or as a side effect of drugs. Mood stabilizer induced priapism has been reported less frequently compared to other psychotropic agents. This paper reports a case of lamotrigine induced priapism. Case: A 24-year-old patient had a diagnosis of bipolar disorder for 4 years. He had been treated with lamotrigine (200 mg/day), sertraline (25 mg/day) and risperidone (2 mg/day) for last year. He developed priapism one week after the lamotrigine dose was increased to 300 mg/day during a depressive episode. Priapism improved the day after the lamotrigine dose was reduced to 250 mg/day. Conclusion: Epilepsy patients with lamotrigine-induced sexual dysfunction or priapism have been reported previously. In this case, a patient diagnosed with bipolar disorder developed dose dependent lamotrigine-induced priapism. In clinical practice, the possible risk of priapism should be taken into consideration in patients using lamotrigine, especially during dose increases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.